BDNF and Alzheimer disease: Repetitive TMS (rTMS) reduces oxidative stress biomarkers, enhances BDNF levels, and improves connectivity between parietal and hippocampal regions. Clinically, this translates into improvements in cognition, memory, and mood, underscoring its role as a non-invasive neuromodulator therapy for AD.